DK0955064T3 - Fremgangsmåde til fremstilling af lægemiddelkomplekser - Google Patents
Fremgangsmåde til fremstilling af lægemiddelkomplekserInfo
- Publication number
- DK0955064T3 DK0955064T3 DK97924326T DK97924326T DK0955064T3 DK 0955064 T3 DK0955064 T3 DK 0955064T3 DK 97924326 T DK97924326 T DK 97924326T DK 97924326 T DK97924326 T DK 97924326T DK 0955064 T3 DK0955064 T3 DK 0955064T3
- Authority
- DK
- Denmark
- Prior art keywords
- spacer
- drug compound
- bound
- carboxyl groups
- polysaccharide derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14452296 | 1996-06-06 | ||
| EP97924326A EP0955064B1 (en) | 1996-06-06 | 1997-06-05 | Process for producing drug complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0955064T3 true DK0955064T3 (da) | 2004-12-06 |
Family
ID=15364300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97924326T DK0955064T3 (da) | 1996-06-06 | 1997-06-05 | Fremgangsmåde til fremstilling af lægemiddelkomplekser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6291671B1 (pt) |
| EP (1) | EP0955064B1 (pt) |
| JP (1) | JP4137184B2 (pt) |
| CN (1) | CN1227034C (pt) |
| AT (1) | ATE273716T1 (pt) |
| AU (1) | AU723442B2 (pt) |
| CA (1) | CA2257233A1 (pt) |
| DE (1) | DE69730352T2 (pt) |
| DK (1) | DK0955064T3 (pt) |
| EA (1) | EA001897B1 (pt) |
| ES (1) | ES2229355T3 (pt) |
| ID (1) | ID17243A (pt) |
| NO (1) | NO323626B1 (pt) |
| PT (1) | PT955064E (pt) |
| TW (1) | TW409058B (pt) |
| WO (1) | WO1997046261A1 (pt) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW527183B (en) | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| US6835807B1 (en) * | 1998-05-22 | 2004-12-28 | Daiichi Pharmaceuticals Co., Ltd. | Drug complex and drug delivery system |
| CA2412582A1 (en) * | 2000-06-29 | 2002-01-03 | Daiichi Pharmaceutical Co., Ltd. | Dds compound and process for the preparation thereof |
| EP1401875A4 (en) * | 2001-05-04 | 2005-01-26 | Univ Utah Res Found | HYALURONIC ACID-CONTAINING BIOKON JUGATES: TARGETED DELIVERY OF ANTIBODIES TO CANCER CELLS |
| US20030049253A1 (en) * | 2001-08-08 | 2003-03-13 | Li Frank Q. | Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines |
| CA2483696A1 (en) * | 2002-05-06 | 2003-11-20 | University Of Utah Research Foundation | Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
| US7691830B2 (en) * | 2005-02-17 | 2010-04-06 | Clive Elson | Method and composition for treatment of a mucosal tissue disorder |
| WO2006121803A1 (en) | 2005-05-05 | 2006-11-16 | Sensient Flavors Inc. | Production of beta-glucans and mannans |
| WO2007004675A1 (ja) * | 2005-07-06 | 2007-01-11 | Seikagaku Corporation | 薬剤導入光架橋ヒアルロン酸誘導体ゲル |
| ITPD20050242A1 (it) | 2005-08-03 | 2007-02-04 | Fidia Farmaceutici | Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico |
| CN1973902B (zh) * | 2006-12-12 | 2010-11-10 | 东北师范大学 | 以人参多糖为载体的抗肿瘤药物阿霉素复合物及制备方法 |
| US9895449B2 (en) | 2010-05-25 | 2018-02-20 | Syndevrx, Inc. | Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof |
| EP3858385B1 (en) | 2010-05-25 | 2024-09-11 | Syndevrx, Inc. | Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| WO2014057687A1 (ja) | 2012-10-11 | 2014-04-17 | 第一三共株式会社 | 抗体－薬物コンジュゲート |
| JP6272230B2 (ja) | 2012-10-19 | 2018-01-31 | 第一三共株式会社 | 親水性構造を含むリンカーで結合させた抗体−薬物コンジュゲート |
| EA033912B1 (ru) | 2013-04-10 | 2019-12-09 | Синдевркс, Инк. | ИНГИБИТОРЫ MetAP2 И СПОСОБЫ ЛЕЧЕНИЯ ОЖИРЕНИЯ |
| WO2015071841A1 (en) | 2013-11-12 | 2015-05-21 | Druggability Technologies Holdings Limited | Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| KR102351164B1 (ko) | 2013-12-25 | 2022-01-13 | 다이이찌 산쿄 가부시키가이샤 | 항 trop2 항체-약물 컨쥬게이트 |
| KR102510128B1 (ko) | 2014-01-31 | 2023-03-14 | 다이이찌 산쿄 가부시키가이샤 | 항-her2 항체-약물 접합체 |
| JP6612738B2 (ja) | 2014-04-10 | 2019-11-27 | 第一三共株式会社 | 抗ｈｅｒ２抗体−薬物コンジュゲート |
| SG10201907807XA (en) | 2014-04-10 | 2019-09-27 | Daiichi Sankyo Co Ltd | Anti-her3 antibody-drug conjugate |
| IL290959B2 (en) | 2015-06-29 | 2023-04-01 | Daiichi Sankyo Co Ltd | Preparations containing antibody-drug conjugates and methods for their production |
| US9969722B2 (en) | 2015-12-10 | 2018-05-15 | Syndevrx, Inc. | Fumagillol derivatives and polymorphs thereof |
| JP7022066B2 (ja) | 2016-01-11 | 2022-02-17 | シンデブルックス，インコーポレイティド | 代謝機能不全によって引き起こされる腫瘍の治療 |
| AU2017377233B2 (en) | 2016-12-12 | 2024-12-19 | Daiichi Sankyo Company, Limited | Combination of antibody-drug conjugate and immune checkpoint inhibitor |
| IL268102B2 (en) | 2017-01-17 | 2024-12-01 | Daiichi Sankyo Co Ltd | Anti-GPR 20 antibody and anti-GPR 20 antibody-drug conjugate |
| TW202504643A (zh) | 2017-05-15 | 2025-02-01 | 日商第一三共股份有限公司 | 抗體－藥物結合物之用途 |
| SG11202001514XA (en) | 2017-08-31 | 2020-03-30 | Daiichi Sankyo Co Ltd | Novel method for producing antibody-drug conjugate |
| CN111051330A (zh) | 2017-08-31 | 2020-04-21 | 第一三共株式会社 | 抗体-药物缀合物的改进制备方法 |
| EP3794041B1 (en) | 2018-05-18 | 2023-07-12 | Glycotope GmbH | Anti-muc1 antibody |
| AU2019311596A1 (en) | 2018-07-27 | 2021-01-28 | Daiichi Sankyo Company, Limited | Protein recognizing drug moiety of antibody-drug conjugate |
| EA202190403A1 (ru) | 2018-07-31 | 2021-05-24 | Дайити Санкио Компани, Лимитед | Лечение метастатической опухоли головного мозга путем введения конъюгата антитело-лекарственное средство |
| CA3117666A1 (en) | 2018-10-26 | 2020-04-30 | Syndevrx, Inc. | Biomarkers of metap2 inhibitors and applications thereof |
| MX2022000450A (es) | 2019-07-10 | 2022-04-25 | Cybrexa 3 Inc | Conjugados peptídicos de agentes dirigidos a microtúbulos como terapéuticos. |
| PE20220563A1 (es) | 2019-07-10 | 2022-04-13 | Cybrexa 2 Inc | Conjugados peptidicos de citotoxinas como terapeuticos |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5746920A (en) * | 1980-09-03 | 1982-03-17 | Kyosei Seiyaku Kk | Drug for digestive tract |
| DE3152319C2 (de) | 1980-09-03 | 1986-05-07 | Kyosei Pharmaceutical Co., Ltd., Hokkaido | Verwendung einer Lösung eines Salzes der Alginsäure zur Behandlung von Strahlenschäden und Ulcera |
| JPS59220197A (ja) | 1983-05-30 | 1984-12-11 | Snow Brand Milk Prod Co Ltd | 新規な含窒素多糖体およびその製造方法 |
| JP2604930B2 (ja) | 1990-12-14 | 1997-04-30 | 株式会社ディ・ディ・エス研究所 | ヒアルロン酸およびコンドロイチン誘導体 |
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| ATE166361T1 (de) | 1991-02-21 | 1998-06-15 | Drug Delivery System Inst Ltd | Carboxymethylmannoglukan und derivate davon |
| JP3359955B2 (ja) | 1992-07-16 | 2002-12-24 | 第一製薬株式会社 | 抗腫瘍剤 |
| WO1994019376A1 (en) | 1993-02-26 | 1994-09-01 | Drug Delivery System Institute, Ltd. | Polysaccharide derivative and drug carrier |
| JPH0784481A (ja) | 1993-06-26 | 1995-03-31 | Ricoh Co Ltd | 画像形成装置 |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| TW527183B (en) | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| US6299881B1 (en) * | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
-
1997
- 1997-05-31 TW TW086107456A patent/TW409058B/zh not_active IP Right Cessation
- 1997-06-05 DE DE69730352T patent/DE69730352T2/de not_active Expired - Lifetime
- 1997-06-05 DK DK97924326T patent/DK0955064T3/da active
- 1997-06-05 EP EP97924326A patent/EP0955064B1/en not_active Expired - Lifetime
- 1997-06-05 ID IDP971929A patent/ID17243A/id unknown
- 1997-06-05 PT PT97924326T patent/PT955064E/pt unknown
- 1997-06-05 CA CA002257233A patent/CA2257233A1/en not_active Abandoned
- 1997-06-05 AT AT97924326T patent/ATE273716T1/de not_active IP Right Cessation
- 1997-06-05 AU AU29788/97A patent/AU723442B2/en not_active Ceased
- 1997-06-05 EA EA199900002A patent/EA001897B1/ru not_active IP Right Cessation
- 1997-06-05 ES ES97924326T patent/ES2229355T3/es not_active Expired - Lifetime
- 1997-06-05 JP JP50042298A patent/JP4137184B2/ja not_active Expired - Fee Related
- 1997-06-05 US US09/147,341 patent/US6291671B1/en not_active Expired - Fee Related
- 1997-06-05 CN CNB971971153A patent/CN1227034C/zh not_active Expired - Fee Related
- 1997-06-05 WO PCT/JP1997/001915 patent/WO1997046261A1/ja active IP Right Grant
-
1998
- 1998-12-04 NO NO19985667A patent/NO323626B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO323626B1 (no) | 2007-06-18 |
| ATE273716T1 (de) | 2004-09-15 |
| AU723442B2 (en) | 2000-08-24 |
| EA199900002A1 (ru) | 1999-08-26 |
| CN1227500A (zh) | 1999-09-01 |
| TW409058B (en) | 2000-10-21 |
| AU2978897A (en) | 1998-01-05 |
| US6291671B1 (en) | 2001-09-18 |
| EA001897B1 (ru) | 2001-10-22 |
| ES2229355T3 (es) | 2005-04-16 |
| EP0955064A1 (en) | 1999-11-10 |
| PT955064E (pt) | 2004-10-29 |
| DE69730352T2 (de) | 2005-09-08 |
| WO1997046261A1 (en) | 1997-12-11 |
| ID17243A (id) | 1997-12-11 |
| NO985667D0 (no) | 1998-12-04 |
| EP0955064A4 (en) | 2000-12-06 |
| JP4137184B2 (ja) | 2008-08-20 |
| NO985667L (no) | 1999-02-04 |
| EP0955064B1 (en) | 2004-08-18 |
| CN1227034C (zh) | 2005-11-16 |
| DE69730352D1 (de) | 2004-09-23 |
| CA2257233A1 (en) | 1997-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0955064T3 (da) | Fremgangsmåde til fremstilling af lægemiddelkomplekser | |
| FI893467L (fi) | Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi | |
| NO985666L (no) | Medikamentkompleks | |
| FI885623A7 (fi) | Menetelmä lääkeaineina käyttökelpoisten substituoitujen propaani-fosfiinihappoyhdisteiden valmistamiseksi | |
| DE59006824D1 (de) | Verfahren zum immobilisieren von proteinen, peptiden, coenzymen od.dgl. an einem träger. | |
| ATE208827T1 (de) | Konjugate von dns und pns und verfahren zu deren herstellung | |
| ATE551352T1 (de) | Peptidakzeptorbindungsverfahren | |
| NO932232D0 (no) | Organiske cerium (iv)-forbindelser, deres fremstilling oganvendelse | |
| EP0296581A3 (en) | Amino acid 1,2-diketo derivatives as renin inhibitors | |
| FI874865L (fi) | Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi | |
| FI861655L (fi) | Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi | |
| RU93058546A (ru) | Способ получения производных эрголина, фармацевтическая композиция | |
| MY131384A (en) | Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof | |
| EP1336603A4 (en) | METHOD FOR INTRODUCING AN AMINO GROUP AND PROCESS FOR SYNTHESIZING AMINO ACID | |
| SE8502315D0 (sv) | Improved transamination process for producing amino acids | |
| ES542956A0 (es) | Un procedimiento para preparar un derivado de oxazolina | |
| RU93004665A (ru) | Микробиологический способ гидроксилирования азот-гетероциклических-карбоновых кислот | |
| FI942403L (fi) | Menetelmä orgaanisen hapon tai sen suolan valmistamiseksi | |
| BR9811579B1 (pt) | ácidos 3-ciano-2,4-dialógeno-5-fluorobenzóicos e processo para a preparação dos mesmos. | |
| EP0344791A3 (en) | Process for the enzymatic resolution of the optical isomers of racemic ester derivatives of 3-mercapto-2-alkyl-propionic acid | |
| FI885638A7 (fi) | Menetelmä lääkeaineina käyttökelpoisten griseoliinihappomonoesterijohdannaisten valmistamiseksi | |
| EP0226132A3 (de) | Dipeptide mit C-terminalem Phosphinothricin, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses | |
| IT8821757A0 (it) | Processo per la preparazione di prodotti di addizione di ossidi alchidici su composti contenenti idrogeni mobili. | |
| GR3002989T3 (en) | Process for the production of n-acylated mercapto-alpha-amino acids | |
| RU95115861A (ru) | Способ получения мурамилпептидов |